Blood News and Research

RSS

FDA approves use of Menactra for booster vaccination against meningococcal disease

Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration approved use of Menactra® [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] for booster vaccination against meningococcal disease in persons 15 years through 55 years of age.

9 Sep 2014

Cholera against cholera: an interview with Dr Bruce Turnbull, University of Leeds

Cholera bacteria, and other types of bacteria that cause diarrheal diseases, infect your intestines where they release AB5 protein toxins – that is they have a single toxic A-subunit that is linked to a pentamer of B-subunits that act as the delivery vehicle to transport the A-subunit into the cells.

8 Sep 2014

Morning hypertension unmasked as risk factor for cardiovascular events

Patients on antihypertensive medication who have high blood pressure in the morning, as measured with home monitoring kits, are at increased risk of cardiovascular events, even if their clinic measurement is acceptable, researchers have found.

8 Sep 2014

Canada funds 22 inventive ideas for improving health in low-resource countries

Grand Challenges Canada, funded by the Government of Canada, today announced $2.4 million in seed funds shared between 22 projects from Canada and nine developing nations, to pursue inventive new ideas for improving health in low-resource countries.

8 Sep 2014

Restarting infliximab therapy after drug holiday is safe for patients with IBD

Restarting infliximab therapy after a drug holiday is safe and effective for patients with inflammatory bowel disease (IBD), according to a new study1 in Clinical Gastroenterology and Hepatology, the official clinical practice journal of the American Gastroenterological Association.

8 Sep 2014

Endo International introduces topical testosterone gel, FORTESTA Gel

Endo International plc announced today that it has introduced the first and only generic 2% topical testosterone gel, an authorized generic of FORTESTA® Gel (testosterone gel) CIII.

8 Sep 2014

Synthetic platelet-like particles could augment natural blood clotting for treatment of traumatic injuries

A new class of synthetic platelet-like particles could augment natural blood clotting for the emergency treatment of traumatic injuries - and potentially offer doctors a new option for curbing surgical bleeding and addressing certain blood clotting disorders without the need for transfusions of natural platelets.

8 Sep 2014

Scientists identify how immune cells use two critical receptors to clear dead cells from the body

In most of the tissues of the body, specialized immune cells are entrusted with the task of engulfing the billions of dead cells that are generated every day.

8 Sep 2014

Researchers measure stiffness of membrane surrounding red blood cells over time

It may look like fresh blood and flow like fresh blood, but the longer blood is stored, the less it can carry oxygen into the tiny microcapillaries of the body, says a new study from University of Illinois researchers.

8 Sep 2014

Eating food just before taking TB drug could reduce effectiveness of medicine

The timing of food intake in the early phase of TB treatment could have a negative impact on the effectiveness of TB treatment.

8 Sep 2014

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today the acquisition of a novel orphan drug candidate, known as SGX301 (synthetic hypericin).

8 Sep 2014

Researchers make important progress in defining new genetic causes of Wilms tumor

Researchers at UT Southwestern Medical Center and the Gill Center for Cancer and Blood Disorders at Children's Medical Center, Dallas, have made significant progress in defining new genetic causes of Wilms tumor, a type of kidney cancer found only in children.

6 Sep 2014

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Keryx Biopharmaceuticals, Inc. today announced that the U.S. Food and Drug Administration approved Ferric Citrate (formerly known as Zerenex) for the control of serum phosphorus levels in patients with chronic kidney disease (CKD) on dialysis.

6 Sep 2014

Viewpoints: Rove renews attack on health law; Calif. 'vaccination crisis'

The disconnect between what Americans think of most provisions of Obamacare (love them!) and what they think of "Obamacare" (hate it!) has been the most perplexing aspect of rollout of the Affordable Care Act.

5 Sep 2014

Longer looks: Alzheimer's and a marriage; racism in medicine; abortion restrictions in Texas

The US, which has a mostly private health-care system, manages to spend more on its public health-care system than countries where the health-care system is almost entirely public. America's government spends more, as a percentage of the economy, on public health care than Canada, the United Kingdom, Japan or Australia. And then it spends even more than that on private health care.

5 Sep 2014

Researchers to study effectiveness of atorvastatin in preventing heart problems in breast cancer patients

Wake Forest Baptist Medical Center has been awarded $4.4 million to conduct a multiple-site clinical trial testing the effectiveness of a statin drug in preventing cardiovascular events in women treated for breast cancer.

5 Sep 2014

Avian influenza A H3N8 virus poses threat to humans

A study led by St. Jude Children's Research Hospital scientists found the avian influenza A H3N8 virus that killed harbor seals along the New England coast can spread through respiratory droplets and poses a threat to humans.

5 Sep 2014

DaVita Kidney Care hosts online Google+ Hangout on Air

DaVita Kidney Care, a division of DaVita HealthCare Partners Inc. and a leading provider of kidney care services, will host an online Google+ Hangout on Air called "Kidney Diet Tips: Diabetes Edition" on Monday, Sept. 8 at 5:00 p.m. PT/8:00 p.m. ET.

4 Sep 2014

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Fractyl Laboratories Inc. today announced positive clinical data for the first procedural therapy to directly treat the underlying digestive causes of insulin resistance in patients with uncontrolled type 2 diabetes.

4 Sep 2014

Codman Neuro Receives Approval for REVIVE SE Thrombectomy Device in China, South Korea and Taiwan

Codman Neuro, part of DePuy Synthes Companies of Johnson & Johnson, announced regulatory approval from the China Food and Drug Administration, South Korea’s Ministry of Food and Drug Safety, and the Taiwan Food and Drug Administration for the company’s REVIVE SE Thrombectomy Device, a next-generation self-expanding clot removal device intended to restore blood flow in patients with acute ischemic stroke secondary to intracranial occlusive vessel disease.

4 Sep 2014

Blood News and Research

FDA approves use of Menactra for booster vaccination against meningococcal disease

Cholera against cholera: an interview with Dr Bruce Turnbull, University of Leeds

Morning hypertension unmasked as risk factor for cardiovascular events

Canada funds 22 inventive ideas for improving health in low-resource countries

Restarting infliximab therapy after drug holiday is safe for patients with IBD

Endo International introduces topical testosterone gel, FORTESTA Gel

Synthetic platelet-like particles could augment natural blood clotting for treatment of traumatic injuries

Scientists identify how immune cells use two critical receptors to clear dead cells from the body

Researchers measure stiffness of membrane surrounding red blood cells over time

Eating food just before taking TB drug could reduce effectiveness of medicine

Soligenix acquires novel orphan drug candidate for treatment of CTCL

Researchers make important progress in defining new genetic causes of Wilms tumor

FDA approves Ferric Citrate for control of serum phosphorus levels in CKD patients on dialysis

Viewpoints: Rove renews attack on health law; Calif. 'vaccination crisis'

Longer looks: Alzheimer's and a marriage; racism in medicine; abortion restrictions in Texas

Researchers to study effectiveness of atorvastatin in preventing heart problems in breast cancer patients

Avian influenza A H3N8 virus poses threat to humans

DaVita Kidney Care hosts online Google+ Hangout on Air

Positive clinical data for first procedural therapy to treat type 2 diabetes from Fractyl

Codman Neuro Receives Approval for REVIVE SE Thrombectomy Device in China, South Korea and Taiwan

Event guide: 4th Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit eBook

Improving healthcare sustainability through carbon data

A New Approach to Preventing Bladder Cancer Recurrence

Bringing real-time analytics to downstream bioprocess monitoring

Latest News